Update for customers, suppliers, and governments
Industry learning and growth
As the world navigates the greatest public health crisis in recent memory, the biopharma industry has taken a leading role in fighting COVID-19. In collaboration with Longitude, a Financial Times company, Cytiva has developed the Global Biopharma Resilience Index. This index ranks biopharma capabilities and resilience in 20 countries, scoring each on five factors critical to meeting global demand during a public health crisis.
The COVID-19 crisis has brought together the scientific community like never before. Our global team is helping to accelerate the work of researchers, developers, and manufacturers of diagnostics and vaccines, to bring access to much-needed solutions for COVID-19.
- Genedrive: PCR assay to detect SARS-CoV-2
- Sona Nanotech: rapid response lateral flow test
- Avacta: Affimer-based point-of-care rapid screening test
- Entos Pharmaceuticals: downstream purification method for protein-based vaccine
- Takara Bio: plasmid vaccine
- Aptamer Group: rapid response lateral flow test
- Prestige Biopharma: manufacture Russia's Sputnik V COVID-19 vaccine
Diagnostic assay development
In response to COVID-19, many diagnostic laboratories and test developers are urgently working to design, manufacture, and validate assays. With over 40 years of experience in diagnostics, we are here to support you from product concept to commercialization. Explore solutions to help develop and manufacture your COVID-19 detection assay, from molecular diagnostics to lateral flow immunoassays.
Vaccine manufacture can have its challenges, from purification to production scale-up. Increase your opportunity to address vaccine manufacturing needs for COVID-19 and other infectious diseases. Explore manufacturing process strategies based on flexible single-use technologies that can help enhance productivity, resulting in more cost-efficient scalable processes, and reduced timelines.
Service and security of supply
Cytiva has comprehensive crisis management and security of supply programs in place. We are committed to fulfilling customer orders and service orders, and regularly adjust our manufacturing output to respond to market demands, while ensuring our operations and service capabilities continue safely.
Meetings and events
We recognize that travel restrictions and local guidelines can limit attendance to in-person events, conferences, and tradeshows. To ensure that we stay connected, we are offering many virtual and hybrid (online/onsite) events. Follow us on LinkedIn, Twitter, Facebook, and email to stay up-to-date with the latest news and events in your region.